FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1485202089> ?p ?o ?g. }

• W1485202089 endingPage "23" @default.
• W1485202089 startingPage "1" @default.
• W1485202089 abstract "In the last decade, standard of care (SOC) anti-HCV treatment has been represented by the combination of Peginterferon (Peg-IFN) plus ribavirin (Rbv). The main disadvantages of Peg-IFN plus Rbv therapy were suboptimal rates of sustained virological response (SVR) in difficult-to-treat patients and side effects profile resulting in poor tolerability. Therefore, strategies to improve SVR rates and limited side effects have been an important issue for clinical physicians. Recently, direct antiviral agents (DAAs) opened the gate for a new era for management of HCV and have revolutionized the treatment of chronic hepatitis c (CHC) patients. Furthermore, the approval of sofosbuvir by FDA represents the first key step towards the new era in the management of CHC patients, since it is the first approved DAAs with excellent tolerability and favorable pharmacokinetic profile, limited potential for drug interactions, higher specificity, shorter treatment durations, low side effects, oral administration, potent antiviral activity and high genetic barrier against all HCV genotypes and acts as a chain terminator during the HCV replication process. Sofosbuvir efficacy and safety was demonstrated in many large and well-designed phase 2 and phase 3 clinical trials like PROTON, ATOMIC, NEUTRINO, ELECTRON, QUANTUM, FISSION, FUSION, POSITRON and LONSTAR studies. In this concept, sofosbuvir represents an almost ideal backbone, especially in difficult-to-treatCHCpatients with cirrhosis or liver impairment, liver transplant recipients, and co-infection with HIV. This review summarizes the development of different anti-HCV agents, and also provides an overview of sofosbuvir clinical efficacy and discussing key results and potential future developments." @default.
• W1485202089 created "2016-06-24" @default.
• W1485202089 creator A5023504173 @default.
• W1485202089 creator A5043318606 @default.
• W1485202089 date "2015-05-29" @default.
• W1485202089 modified "2023-09-23" @default.
• W1485202089 title "Medication of Chronic Hepatitis C: A Review on Sofosbuvir as a New Antiviral Drug" @default.
• W1485202089 cites W1644221808 @default.
• W1485202089 cites W1815984339 @default.
• W1485202089 cites W1967785127 @default.
• W1485202089 cites W1977300462 @default.
• W1485202089 cites W1979574442 @default.
• W1485202089 cites W1987935503 @default.
• W1485202089 cites W1991105141 @default.
• W1485202089 cites W1993274621 @default.
• W1485202089 cites W2000336618 @default.
• W1485202089 cites W2001022777 @default.
• W1485202089 cites W2001115724 @default.
• W1485202089 cites W2002142691 @default.
• W1485202089 cites W2002927032 @default.
• W1485202089 cites W2004560175 @default.
• W1485202089 cites W2011707824 @default.
• W1485202089 cites W2017589955 @default.
• W1485202089 cites W2022004872 @default.
• W1485202089 cites W2026822625 @default.
• W1485202089 cites W2027545702 @default.
• W1485202089 cites W2033555988 @default.
• W1485202089 cites W2044547797 @default.
• W1485202089 cites W2047089913 @default.
• W1485202089 cites W2048778984 @default.
• W1485202089 cites W2048873689 @default.
• W1485202089 cites W2051448425 @default.
• W1485202089 cites W2054553813 @default.
• W1485202089 cites W2054768505 @default.
• W1485202089 cites W2055540046 @default.
• W1485202089 cites W2062282550 @default.
• W1485202089 cites W2062417943 @default.
• W1485202089 cites W2064569884 @default.
• W1485202089 cites W2067182451 @default.
• W1485202089 cites W2068253682 @default.
• W1485202089 cites W2072160870 @default.
• W1485202089 cites W2078251659 @default.
• W1485202089 cites W2085652845 @default.
• W1485202089 cites W2089829321 @default.
• W1485202089 cites W2106172816 @default.
• W1485202089 cites W2106378149 @default.
• W1485202089 cites W2107121700 @default.
• W1485202089 cites W2108694342 @default.
• W1485202089 cites W2111044696 @default.
• W1485202089 cites W2112557631 @default.
• W1485202089 cites W2112876622 @default.
• W1485202089 cites W2117115804 @default.
• W1485202089 cites W2120733999 @default.
• W1485202089 cites W2121769769 @default.
• W1485202089 cites W2123251487 @default.
• W1485202089 cites W2123348911 @default.
• W1485202089 cites W2126985219 @default.
• W1485202089 cites W2127685726 @default.
• W1485202089 cites W2133036275 @default.
• W1485202089 cites W2136117244 @default.
• W1485202089 cites W2136218615 @default.
• W1485202089 cites W2138215924 @default.
• W1485202089 cites W2138363476 @default.
• W1485202089 cites W2141200498 @default.
• W1485202089 cites W2145631850 @default.
• W1485202089 cites W2148073911 @default.
• W1485202089 cites W2148796329 @default.
• W1485202089 cites W2148840656 @default.
• W1485202089 cites W2150875695 @default.
• W1485202089 cites W2153237405 @default.
• W1485202089 cites W2159739349 @default.
• W1485202089 cites W2164466220 @default.
• W1485202089 cites W2187843068 @default.
• W1485202089 cites W2314619766 @default.
• W1485202089 cites W2317872626 @default.
• W1485202089 cites W2324539587 @default.
• W1485202089 cites W2332630894 @default.
• W1485202089 cites W2411387361 @default.
• W1485202089 cites W2468922034 @default.
• W1485202089 cites W2472116384 @default.
• W1485202089 cites W2011615511 @default.
• W1485202089 cites W2781322779 @default.
• W1485202089 hasPublicationYear "2015" @default.
• W1485202089 type Work @default.
• W1485202089 sameAs 1485202089 @default.
• W1485202089 citedByCount "0" @default.
• W1485202089 crossrefType "journal-article" @default.
• W1485202089 hasAuthorship W1485202089A5023504173 @default.
• W1485202089 hasAuthorship W1485202089A5043318606 @default.
• W1485202089 hasConcept C126322002 @default.
• W1485202089 hasConcept C159047783 @default.
• W1485202089 hasConcept C177713679 @default.
• W1485202089 hasConcept C197934379 @default.
• W1485202089 hasConcept C2522874641 @default.
• W1485202089 hasConcept C2776408679 @default.
• W1485202089 hasConcept C2776455275 @default.
• W1485202089 hasConcept C2776461080 @default.
• W1485202089 hasConcept C2777214474 @default.

• next